Issue 1/2020
Content (18 Articles)
Guidance of healthcare development for metastatic cancer patients as an example for setting incentives
Jörg Haier, Jonathan Sleeman, Jürgen Schäfers
Companion canines: an under-utilised model to aid in translating anti-metastatics to the clinic
Louise van der Weyden, Mike Starkey, Bushra Abu-Helil, Anthony J. Mutsaers, Geoffrey A. Wood
Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond
Maria V. Deligiorgi, Mihalis I. Panayiotidis, John Griniatsos, Dimitrios T. Trafalis
Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis
Padacherri Vethil Jishnu, Pradyumna Jayaram, Vaibhav Shukla, Vinay Koshy Varghese, Deeksha Pandey, Krishna Sharan, Sanjiban Chakrabarty, Kapaettu Satyamoorthy, Shama Prasada Kabekkodu
The contribution of platelets to intravascular arrest, extravasation, and outgrowth of disseminated tumor cells
Amelia Foss, Leonel Muñoz-Sagredo, Jonathan Sleeman, Wilko Thiele
Tissue inhibitor of matrix metalloproteinase-3 has both anti-metastatic and anti-tumourigenic properties
Geetanjali P. Rai, Sarah K. Baird
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis
Luca Nicosia, Vanessa Figlia, Rosario Mazzola, Giuseppe Napoli, Niccolò Giaj-Levra, Francesco Ricchetti, Michele Rigo, Gianluigi Lunardi, Davide Tomasini, Marco L. Bonù, Stefanie Corradini, Ruggero Ruggieri, Filippo Alongi
Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study
Mustafa S. Ascha, Kaitlyn Funk, Andrew E. Sloan, Carol Kruchko, Jill S. Barnholtz-Sloan
Quality of life in patients with liver tumors treated with holmium-166 radioembolization
Caren van Roekel, Maarten L. J. Smits, Jip F. Prince, Rutger C. G. Bruijnen, Maurice A. A. J. van den Bosch, Marnix G. E. H. Lam
Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes
Austin B. Gardner, Lindsey M. Charo, Amandeep K. Mann, Daniel S. Kapp, Ramez N. Eskander, John K. Chan
Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma
Jiayu Zhou, Shizhen Zhang, Yong Xu, Weiwen Ye, Zhijun Li, Zhoumiao Chen, Zhengfu He
The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02
Jeong Won Lee, Dongryul Oh, Keun-Yong Eom, Jin Hee Kim, Woo Chul Kim, Mi Joo Chung, Jong Hoon Lee
Adaptation to chronic acidic extracellular pH elicits a sustained increase in lung cancer cell invasion and metastasis
Shusaku Sutoo, Toyonobu Maeda, Atsuko Suzuki, Yasumasa Kato
CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway
Hiroaki Yasui, Hiroaki Kajiyama, Satoshi Tamauchi, Shiro Suzuki, Yang Peng, Nobuhisa Yoshikawa, Mai Sugiyama, Kae Nakamura, Fumitaka Kikkawa
Gene expression signatures of site-specificity in cancer metastases
Franz Hartung, Aditya Patil, Rohan J. Meshram, Georg F. Weber
PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells
Yongming Xi, Zonghua Qi, Jinfeng Ma, Yan Chen
Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer
Stephanie Metcalf, Susan Dougherty, Traci Kruer, Nazarul Hasan, Rumeysa Biyik-Sit, Lindsey Reynolds, Brian F. Clem
Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model
Chinami Masuda, Masamichi Sugimoto, Daiko Wakita, Makoto Monnai, Chisako Ishimaru, Ryo Nakamura, Mari Kinoshita, Keigo Yorozu, Mitsue Kurasawa, Osamu Kondoh, Kaname Yamamoto